Showing 1061-1070 of 2115 results for "".
Late-Stage Drugs for Atopic Dermatitis: An Update
https://practicaldermatology.com/topics/atopic-dermatitis/late-stage-drugs-for-atopic-dermatitis-an-update/23373/Here’s a look at investigational agents for this common disease.COVID-19 Will Eventually End, But Telemedicine is Here to Stay
https://practicaldermatology.com/topics/practice-management/covid-19-will-eventually-end-but-telemedicine-is-here-to-stay/23348/As dermatology practices consider next steps regarding virtual care visits, it’s important to look beyond the basic platforms and establish a safer, more userfriendly telemedicine strategy.UCB: Committed to Driving Immuno-dermatology Forward
https://practicaldermatology.com/topics/psoriasis/ucb-committed-to-driving-immuno-dermatology-forward/23327/Skin of Color Treatment: Glows and Grows from the Pros
https://practicaldermatology.com/topics/skin-of-color/skin-of-color-treatment-glows-and-grows-from-the-pros/23232/Updates from the Skin of Color Society’s Annual Media DayCurrents: Best Face Forward
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-best-face-forward/23190/Updates on Aesthetic Trends and Practice Strategies for 2020EBDs, CBD, Millennials, and More in the Mix at CSF
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/ebds-cbd-millennials-and-more-in-the-mix-at-csf/23131/Get the scoop on what will happen live at CSF 2019!New Products/New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-otc-3/23108/Currents: Targeted Opportunities
https://practicaldermatology.com/topics/practice-management/currents-targeted-opportunities/23097/Reach your goals in dermatology practice.New Products/New In My Practice: Sunscreen
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-sunscreen/23087/You Don’t Have Male
https://practicaldermatology.com/topics/practice-management/you-dont-have-male/23084/Male cosmetic patients are hard to come by. Here’s why!